IDO1 and neoplasm: The AKR1C3+ cells could catalyze the paclitaxel to the non-toxic hydroxyl metabolites, accompanied with activated ROS and inflammation; the IDO1+ cells may inhibit T cell function by consuming tyrosine and HEY1+ cells enhanced the cell proliferation to promote tumor survival.